Effect of internet-based vs. in-person multimodal interventions on patients with mild to moderate Alzheimer's disease: a randomized, cross-over, open-label trial

被引:3
|
作者
Jung, Young Hee [1 ]
Park, Sang-Cheol [2 ]
Lee, Jee Hee [3 ]
Kim, Myong Jong [4 ]
Lee, Seunghoon [5 ]
Chung, Su Jin [1 ]
Moon, Ji Yeon [1 ]
Choi, Young Hi [6 ]
Ju, Jieun [4 ]
Han, Hyun Jeong [1 ]
Lee, So Young [4 ]
机构
[1] Hanyang Univ, Myongji Hosp, Dept Neurol, Coll Med, Goyang, South Korea
[2] Myongji Hosp, Artificial Intelligence & Robot Lab, Goyang, South Korea
[3] Hanyang Univ, Myongji Hosp, Dept Publ Hlth & Healthcare Serv, Coll Med, Goyang, South Korea
[4] Hanyang Univ, Myongji Hosp, Ctr Arts & Healing, Coll Med, Goyang, South Korea
[5] Hanyang Univ, Myongji Hosp, Dept Psychiat, Coll Med, Goyang, South Korea
[6] Cheongpungho Geriatr Hosp, Jecheon, South Korea
关键词
Alzheimer's disease; in-person; internet-based; art therapy; music therapy; multimodal intervention; MUSIC-THERAPY; COGNITIVE INTERVENTION; PHYSICAL-ACTIVITY; DEMENTIA; POPULATION; DEPRESSION; IMPAIRMENT; ANXIETY; DECLINE; ART;
D O I
10.3389/fpubh.2023.1203201
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
ObjectiveWe aimed to investigate the effect of internet-based and in-person cognitive interventions on cognition, mood, and activities of daily living (ADL) on patients with mild to moderate Alzheimer's disease (AD) and examine whether internet-based intervention is as effective as the in-person intervention. MethodsWe recruited 52 patients with probable mild AD, of whom 42 completed the trial. We randomly divided participants into intervention and control groups at a 1:1 ratio and statistically compared the neuropsychological test results of the two groups. In addition, patients in the intervention group were randomly assigned to a 4 weeks internet-based or in-person intervention, with subsequent crossover to the other group for 4 weeks. We statistically analyzed and compared the neuropsychological test scores between internet-based and in-person interventions. ResultsCompared with the control group, the intervention group (internet-based and in-person) showed significantly improved profile in cognition (p < 0.001), depression (p < 0.001), anxiety (p < 0.001) and ADL (p < 0.001). In addition, the effect of the internet-based intervention on cognition (p = 0.918) and depression (p = 0.282) was not significantly different from that of the in-person intervention. However, in the Beck anxiety inventory (p = 0.009) and Seoul instrumental activity of daily living (p = 0.023), in-person intervention was more effective than internet-based intervention. ConclusionThis study suggests that both types of cognitive intervention (in-person and internet-based) may be viable supplementary treatments along with approved pharmacological therapy. In terms of anxiety and ADL, the effect of the in-person interventions may be more effective than the-internet based interventions.
引用
收藏
页数:9
相关论文
共 50 条
  • [1] An exploratory, open-label, randomized, multicenter trial of hachimijiogan for mild Alzheimer's disease
    Kainuma, Mosaburo
    Ouma, Shinji
    Kawakatsu, Shinobu
    Iritani, Osamu
    Yamashita, Ken-Ichiro
    Ohara, Tomoyuki
    Hirano, Shigeki
    Suda, Shiro
    Hamano, Tadanori
    Hieda, Sotaro
    Yasui, Masaaki
    Yoshiiwa, Aoi
    Shiota, Seiji
    Hironishi, Masaya
    Wada-Isoe, Kenji
    Sasabayashi, Daiki
    Yamasaki, Sho
    Murata, Masayuki
    Funakoshi, Kouta
    Hayashi, Kouji
    Shirafuji, Norimichi
    Sasaki, Hirohito
    Kajimoto, Yoshinori
    Mori, Yukiko
    Suzuki, Michio
    Ito, Hidefumi
    Ono, Kenjiro
    Tsuboi, Yoshio
    [J]. FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [2] Efficacy of levodopa/benserazide dispersible tablet on delayed ON in Parkinson's disease patients with motor fluctuations: a multicenter randomized open-label cross-over trial
    Chang, H. J.
    Park, J.
    Oh, S.
    Shin, C. W.
    Cho, J. W.
    Lee, J. Y.
    [J]. MOVEMENT DISORDERS, 2022, 37 : S321 - S321
  • [3] LDL-cholesterol lowering effect of a new dietary supplement: an open label, controlled, randomized, cross-over clinical trial in patients with mild-to-moderate hypercholesterolemia
    S. Magno
    G. Ceccarini
    C. Pelosini
    R. Jaccheri
    J. Vitti
    P. Fierabracci
    G. Salvetti
    G. Airoldi
    M. Minale
    G. Saponati
    F. Santini
    [J]. Lipids in Health and Disease, 17
  • [4] LDL-cholesterol lowering effect of a new dietary supplement: an open label, controlled, randomized, cross-over clinical trial in patients with mild-to-moderate hypercholesterolemia
    Magno, S.
    Ceccarini, G.
    Pelosini, C.
    Jaccheri, R.
    Vitti, J.
    Fierabracci, P.
    Salvetti, G.
    Airoldi, G.
    Minale, M.
    Saponati, G.
    Santini, F.
    [J]. LIPIDS IN HEALTH AND DISEASE, 2018, 17
  • [5] VEgetaRian Diet in patients with Ischemic heart disease (VERDI): an open-label, randomized, prospective, cross-over study
    Djekic, D.
    Carlsson, F.
    Landberg, R.
    Sarnqvist, C.
    Cao, Y.
    Tremaroli, V.
    Backhed, F.
    Frobert, O.
    [J]. EUROPEAN HEART JOURNAL, 2019, 40 : 3819 - 3819
  • [6] Efficacy and Safety of a Transdermal Donepezil Patch in Patients with Mild to Moderate Alzheimer's Disease: Open-Label, Extension Study
    Nakamura, Yu
    Omori, Takumi
    Kim, Rei
    Nishiyama, Kenichi
    Kikuchi, Takashi
    Ishikawa, Ichiro
    Aoki, Hiroshi
    [J]. JOURNAL OF ALZHEIMERS DISEASE, 2023, 94 (02) : 685 - 693
  • [7] Safety and efficacy of donepezil in a 12-week, open-label trial in African Americans with mild to moderate Alzheimer's disease
    Griffith, P
    Lichtenberg, P
    Goldman, R
    Payne-Parrish, J
    Richardson, S
    [J]. NEUROLOGY, 2005, 64 (06) : A366 - A366
  • [8] Effects of Additional Granola in Children's Breakfast on Nutritional Balance, Sleep and Defecation: An Open-Label Randomized Cross-Over Trial
    Matsumoto, Yuma
    Sasaki, Hiroyuki
    Masutomi, Hirofumi
    Ishihara, Katsuyuki
    Shibata, Shigenobu
    Hirao, Kazuko
    Furutani, Akiko
    [J]. CHILDREN-BASEL, 2023, 10 (05):
  • [9] Cooling spray or lidocaine spray and needle insertion pain in hemodialysis patients: an open-label cross-over randomized clinical trial
    Khosravi Pour, Armin
    Hejazi, Sima
    Kameli, Ahmad
    Hoseini Azizi, Tooba
    Armat, Mohammad Reza
    Eshghi, Maesoomeh
    [J]. BMC ANESTHESIOLOGY, 2023, 23 (01)
  • [10] Cooling spray or lidocaine spray and needle insertion pain in hemodialysis patients: an open-label cross-over randomized clinical trial
    Armin Khosravi Pour
    Sima Hejazi
    Ahmad Kameli
    Tooba Hoseini Azizi
    Mohammad Reza Armat
    Maesoomeh Eshghi
    [J]. BMC Anesthesiology, 23